Age
Item
adult patients, >/= 18 years of age
boolean
C0001779 (UMLS CUI [1])
Multiple basal cell carcinomas as for example in gorlin syndromes, at least 6 basal cell carcinomas of which 3 measure at least 5mm in diameter and are considered target lesions
Item
patients with multiple basal cell carcinomas, including patients with gorlin syndrome, with at least 6 clinically evident basal cell carcinomas at the time of randomization, of which 3 measure 5 mm or more in diameter and are considered target lesions. all other lesions are considered to be non-target lesions
boolean
C1854245 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
C1854245 (UMLS CUI [2,1])
C0475440 (UMLS CUI [2,2])
C0004779 (UMLS CUI [3])
C2986546 (UMLS CUI [4])
histopathologic confirmation that at least one of the three target lesions is basal cell carcinoma
Item
histopathologic confirmation that at least one of the three target lesions is basal cell carcinoma
boolean
C0007117 (UMLS CUI [1,1])
C0449575 (UMLS CUI [1,2])
ecog status
Item
eastern cooperative oncology group (ecog) performance status of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
adequate renal and hepatic function and hematopoietic capacity
Item
adequate renal and hepatic function and hematopoietic capacity
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0018951 (UMLS CUI [3])
Women of childbearing potential agreeing to use contraception as defined by protocol
Item
women of childbearing potential must agree to use contraception as defined by protocol during treatment and for at least 7 months after completion of study treatment
boolean
C0043210 (UMLS CUI [1,1])
C3831118 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
male patients with female partners of childbearing potential agreeing to use contraception as defined by protocol
Item
male patients with female partners of childbearing potential must agree to use contraception as defined by protocol during treatment and for 2 months after completion of study treatment
boolean
C0086582 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0682323 (UMLS CUI [1,3])
C3831118 (UMLS CUI [1,4])
inability or unwillingness to swallow capsules
Item
inability or unwillingness to swallow capsules
boolean
C0566355 (UMLS CUI [1,1])
C0006935 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0558080 (UMLS CUI [2,1])
C4521686 (UMLS CUI [2,2])
C0006935 (UMLS CUI [2,3])
pregnancy or breastfeeding
Item
pregnant or breastfeeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
metastatic basal cell carcinoma
Item
any metastatic basal cell carcinoma
boolean
C0007117 (UMLS CUI [1,1])
C0036525 (UMLS CUI [1,2])
inoperable basal cell carcinoma lesion
Item
locally advanced basal cell carcinoma lesion that is considered to be inoperable or to have medical contraindications to surgery
boolean
C0205187 (UMLS CUI [1,1])
C0007117 (UMLS CUI [1,2])
recent or current participation in another experimental drug study
Item
recent (.i.e. within the past 28 days prior to randomization) or current participation in another experimental drug study
boolean
C0521116 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0332185 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
known or suspected alcohol abuse
Item
known or suspected alcohol abuse
boolean
C0085762 (UMLS CUI [1,1])
C0750491 (UMLS CUI [1,2])
C0085762 (UMLS CUI [2])
galactose intolerance, primary hypolactasia or glucose-galactose malabsorption
Item
one of the following known rare hereditary conditions: galactose intolerance, primary hypolactasia or glucose-galactose malabsorption
boolean
C0268186 (UMLS CUI [1])
C0016952 (UMLS CUI [2])
C0022951 (UMLS CUI [3])